Dostarlimab companion diagnostic - Promega corporation/GSK
Alternative Names: Dostarlimab- MSI companion diagnosticLatest Information Update: 24 Nov 2023
At a glance
- Originator GSK; Promega Corporation
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Solid tumours